RMD ResMed Inc

$250.76

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About ResMed Inc

ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions.

Website: https://www.resmed.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
June
CIK
943819
Address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, US
Valuation
Market Cap
$31.27B
P/E Ratio
25.14
PEG Ratio
1.39
Price to Book
5.95
Performance
EPS
$8.47
Dividend Yield
1.00%
Profit Margin
25.40%
ROE
25.70%
Technicals
50D MA
$224.84
200D MA
$231.53
52W High
$262.46
52W Low
$176.89
Fundamentals
Shares Outstanding
147M
Target Price
$266.15
Beta
0.76

RMD EPS Estimates vs Actual

● Estimated
● Actual

RMD News & Sentiment

Nov 19, 2025 • Benzinga SOMEWHAT-BULLISH
Peter C Farrell Exercises Options, Realizes $1.65M - ResMed ( NYSE:RMD )
A substantial insider activity was disclosed on November 18, as Farrell, Board Member at ResMed ( NYSE:RMD ) , reported the exercise of a large sell of company stock options. What Happened: A Form 4 filing from the U.S.
Nov 14, 2025 • GlobeNewswire NEUTRAL
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
INSIDE INFORMATIONREGULATED INFORMATION ...
Nov 13, 2025 • Motley Fool SOMEWHAT-BULLISH
Nyxoah ( NYXH ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, November 13, 2025 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Nov 13, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
INSIDE INFORMATIONREGULATED INFORMATION ...
Nov 13, 2025 • Benzinga SOMEWHAT-BULLISH
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio - Nyxoah ( NASDAQ:NYXH )
Financings are comprised of equity investments, including from Cochlear, Resmed and Nyxoah's Chairman and Management, and a convertible bond.
Nov 12, 2025 • Motley Fool NEUTRAL
Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete?
ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.
Sentiment Snapshot

Average Sentiment Score:

0.332
50 articles with scored sentiment

Overall Sentiment:

Bullish

RMD Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Post market)
0.07 Surprise
  • Reported EPS: $2.55
  • Estimate: $2.48
  • Whisper: —
  • Surprise %: 2.8%
Apr 23, 2025
Mar 31, 2025 (Post market)
0.01 Surprise
  • Reported EPS: $2.37
  • Estimate: $2.36
  • Whisper: —
  • Surprise %: 0.4%
Jan 30, 2025
Dec 31, 2024 (Post market)
0.12 Surprise
  • Reported EPS: $2.43
  • Estimate: $2.31
  • Whisper: —
  • Surprise %: 5.2%
Oct 24, 2024
Sep 30, 2024 (Post market)
0.16 Surprise
  • Reported EPS: $2.20
  • Estimate: $2.04
  • Whisper: —
  • Surprise %: 7.8%
Aug 01, 2024
Jun 30, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $2.08
  • Estimate: $2.07
  • Whisper: —
  • Surprise %: 0.5%
Apr 25, 2024
Mar 31, 2024 (Post market)
0.22 Surprise
  • Reported EPS: $2.13
  • Estimate: $1.91
  • Whisper: —
  • Surprise %: 11.5%
Jan 24, 2024
Dec 31, 2023 (Post market)
0.08 Surprise
  • Reported EPS: $1.88
  • Estimate: $1.80
  • Whisper: —
  • Surprise %: 4.4%
Oct 26, 2023
Sep 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $1.64
  • Estimate: $1.62
  • Whisper: —
  • Surprise %: 1.2%
Aug 03, 2023
Jun 30, 2023 (Post market)
-0.09 Surprise
  • Reported EPS: $1.60
  • Estimate: $1.69
  • Whisper: —
  • Surprise %: -5.3%

Financials